
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1055 | 1055 | 1058 | 1260 | 1877 | - |
Fund Return | 5.51% | 5.51% | 5.84% | 8.01% | 13.42% | - |
Place in category | 822 | 822 | 789 | 510 | 417 | - |
% in Category | 37 | 37 | 38 | 28 | 26 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU2197358042 | 2.54B | -9.13 | 8.99 | - | ||
Cleome Index USA Equities R EUR Acc | 2.54B | -9.19 | 8.75 | 11.26 | ||
Cleome Index USA Equities Y EUR Acc | 2.54B | -9.42 | 7.61 | 10.37 | ||
Cleome Index USA Equities Z EUR Acc | 2.54B | -9.12 | 9.08 | 11.65 | ||
Candriam Equities L Global Demograp | 1.9B | -7.60 | 6.52 | 8.66 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
European Growth Fund A Acc EUR | 160.56M | 4.00 | 8.97 | 4.24 | ||
European Growth Fund E Acc EUR | 21.7M | 3.80 | 8.15 | 3.46 | ||
European Growth Fund Y Acc EUR | 193.86M | 4.21 | 9.89 | 5.11 | ||
European Growth Fund Y DIST EUR | 62.66M | 4.24 | 9.91 | 5.11 | ||
European Growth Fund A DIST Eue | 6.35B | 4.01 | 8.97 | 4.24 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
SAP | DE0007164600 | 2.54 | 230.075 | +0.56% | |
Novo Nordisk B | DK0062498333 | 2.49 | 436.6 | +0.17% | |
ASML Holding | NL0010273215 | 2.41 | 602.90 | +2.19% | |
Nestle | CH0038863350 | 2.20 | 85.57 | -0.56% | |
Roche Holding Participation | CH0012032048 | 2.05 | 251.20 | -0.20% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Neutral |
Technical Indicators | Strong Sell | Strong Sell | Sell |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review